Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2024-06-03 Sale |
2024-06-04 4:22 pm |
bluebird bio Inc. | BLUE | Klima Thomas J See Remarks |
3,834 | $0.9719 | $3,726 | 121,006 (Direct) |
View |
2024-03-01 Sale |
2024-03-05 5:40 pm |
bluebird bio Inc. | BLUE | Colvin Richard A Chief Medical Officer |
6,770 | $1.5276 | $10,342 | 317,368 (Direct) |
View |
2024-03-04 Sale |
2024-03-05 5:40 pm |
bluebird bio Inc. | BLUE | Obenshain Andrew President and CEO |
6,095 | $1.5276 | $9,311 | 929,998 (Direct) |
View |
2024-03-04 Sale |
2024-03-05 5:39 pm |
bluebird bio Inc. | BLUE | Klima Thomas J See Remarks |
4,573 | $1.5276 | $6,986 | 323,840 (Direct) |
View |
2024-02-05 Sale |
2024-02-06 4:07 pm |
bluebird bio Inc. | BLUE | Klima Thomas J See Remarks |
2,714 | $0.9025 | $2,449 | 129,413 (Direct) |
View |
2024-02-05 Sale |
2024-02-06 4:07 pm |
bluebird bio Inc. | BLUE | Vittiglio Joseph Chief Business & Legal Officer |
5,217 | $0.9025 | $4,708 | 44,783 (Direct) |
View |
2024-02-05 Sale |
2024-02-06 4:07 pm |
bluebird bio Inc. | BLUE | Obenshain Andrew President and CEO |
1,879 | $0.9025 | $1,696 | 286,093 (Direct) |
View |
2024-01-05 Sale |
2024-01-09 4:05 pm |
bluebird bio Inc. | BLUE | Obenshain Andrew President and CEO |
3,162 | $1.4294 | $4,520 | 287,972 (Direct) |
View |
2024-01-05 Sale |
2024-01-09 4:05 pm |
bluebird bio Inc. | BLUE | Colvin Richard A Chief Medical Officer |
597 | $1.415 | $845 | 125,138 (Direct) |
View |
2023-12-06 Sale |
2023-12-08 4:42 pm |
bluebird bio Inc. | BLUE | Krawtschuk Christopher Chief Financial Officer |
4,526 | $4.5155 | $20,437 | 45,474 (Direct) |
View |
2023-11-03 Sale |
2023-11-03 4:10 pm |
bluebird bio Inc. | BLUE | Obenshain Andrew President and CEO |
807 | $3.1659 | $2,555 | 291,134 (Direct) |
View |
2023-11-02 Sale |
2023-11-03 4:10 pm |
bluebird bio Inc. | BLUE | Colvin Richard A Chief Medical Officer |
2,343 | $2.9769 | $6,975 | 125,735 (Direct) |
View |
2023-09-05 Sale |
2023-09-06 4:30 pm |
bluebird bio Inc. | BLUE | Klima Thomas J See Remarks |
922 | $3.7886 | $3,493 | 132,127 (Direct) |
View |
2023-08-10 Sale |
2023-08-10 5:00 pm |
bluebird bio Inc. | BLUE | Obenshain Andrew President and CEO |
16,929 | $3.5416 | $59,956 | 291,941 (Direct) |
View |
2023-06-02 Sale |
2023-06-06 4:06 pm |
bluebird bio Inc. | BLUE | Klima Thomas J See Remarks |
4,130 | $3.499 | $14,451 | 133,049 (Direct) |
View |
2022-10-17 Sale |
2023-03-09 4:06 pm |
bluebird bio Inc. | BLUE | Leiderman Elisabeth Director |
1,004 | $6.4643 | $6,490 | 11,466 (Direct) |
View |
2023-01-11 Sale |
2023-01-13 4:19 pm |
bluebird bio Inc. | BLUE | Obenshain Andrew President and CEO |
3,178 | $7.8043 | $24,802 | 242,690 (Direct) |
View |
2023-01-11 Sale |
2023-01-13 4:19 pm |
bluebird bio Inc. | BLUE | Colvin Richard A Chief Medical Officer |
557 | $7.8043 | $4,347 | 74,231 (Direct) |
View |
2023-01-11 Sale |
2023-01-13 4:19 pm |
bluebird bio Inc. | BLUE | Leschly Nick Director |
4,290 | $7.8043 | $33,480 | 448,848 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2024-03-01 Option Award |
2024-03-05 5:40 pm |
N/A 2034-03-01 |
bluebird bio Inc. | BLUE | Colvin Richard A Chief Medical Officer |
199,000 | $0 | 317,368 (Direct) |
View |
2024-03-01 Option Award |
2024-03-05 5:40 pm |
N/A 2034-03-01 |
bluebird bio Inc. | BLUE | Vittiglio Joseph Chief Business & Legal Officer |
199,000 | $0 | 199,000 (Direct) |
View |
2024-03-01 Option Award |
2024-03-05 5:40 pm |
N/A 2034-03-01 |
bluebird bio Inc. | BLUE | Obenshain Andrew President and CEO |
650,000 | $0 | 929,998 (Direct) |
View |
2024-03-01 Option Award |
2024-03-05 5:39 pm |
N/A 2034-03-01 |
bluebird bio Inc. | BLUE | Krawtschuk Christopher Chief Financial Officer |
199,000 | $0 | 199,000 (Direct) |
View |
2024-03-01 Option Award |
2024-03-05 5:39 pm |
N/A 2034-03-01 |
bluebird bio Inc. | BLUE | Klima Thomas J See Remarks |
199,000 | $0 | 323,840 (Direct) |
View |
2023-06-16 Option Award |
2023-06-20 4:31 pm |
N/A 2033-06-16 |
bluebird bio Inc. | BLUE | Tita-Reid Najoh Director |
32,390 | $0 | 44,860 (Direct) |
View |
2023-06-16 Option Award |
2023-06-20 4:31 pm |
N/A 2033-06-16 |
bluebird bio Inc. | BLUE | Agwunobi John O Director |
32,390 | $0 | 48,064 (Direct) |
View |
2023-06-16 Option Award |
2023-06-20 4:31 pm |
N/A 2033-06-16 |
bluebird bio Inc. | BLUE | Vachon Mark Director |
32,390 | $0 | 46,641 (Direct) |
View |
2023-06-16 Option Award |
2023-06-20 4:31 pm |
N/A 2033-06-16 |
bluebird bio Inc. | BLUE | Leschly Nick Director |
32,390 | $0 | 481,238 (Direct) |
View |
2023-06-16 Option Award |
2023-06-20 4:30 pm |
N/A 2033-06-16 |
bluebird bio Inc. | BLUE | Leiderman Elisabeth Director |
32,390 | $0 | 43,856 (Direct) |
View |
2023-06-16 Option Award |
2023-06-20 4:30 pm |
N/A 2033-06-16 |
bluebird bio Inc. | BLUE | Jones-Burton Charlotte Director |
32,390 | $0 | 40,162 (Direct) |
View |
2023-04-03 Option Award |
2023-04-05 4:07 pm |
N/A 2033-04-03 |
bluebird bio Inc. | BLUE | Paulson Richard A. Director |
12,163 | $0 | 12,163 (Direct) |
View |
2023-03-01 Option Award |
2023-03-03 4:43 pm |
N/A 2033-03-01 |
bluebird bio Inc. | BLUE | Colvin Richard A Chief Medical Officer |
165,000 | $0 | 238,078 (Direct) |
View |
2023-03-01 Option Award |
2023-03-03 4:43 pm |
N/A 2033-03-01 |
bluebird bio Inc. | BLUE | Obenshain Andrew President and CEO |
405,600 | $0 | 646,870 (Direct) |
View |
2023-03-01 Option Award |
2023-03-03 4:43 pm |
N/A 2033-03-01 |
bluebird bio Inc. | BLUE | Klima Thomas J See Remarks |
165,000 | $0 | 247,179 (Direct) |
View |
2023-02-01 Tax Withholding |
2023-02-03 4:06 pm |
N/A N/A |
bluebird bio Inc. | BLUE | Klima Thomas J See Remarks |
2,260 | $6.38 | 82,179 (Direct) |
View |
2023-02-01 Tax Withholding |
2023-02-03 4:05 pm |
N/A N/A |
bluebird bio Inc. | BLUE | Colvin Richard A Chief Medical Officer |
1,153 | $6.38 | 73,078 (Direct) |
View |
2023-02-01 Tax Withholding |
2023-02-03 4:05 pm |
N/A N/A |
bluebird bio Inc. | BLUE | Obenshain Andrew President and CEO |
1,420 | $6.38 | 241,270 (Direct) |
View |
2023-02-01 Option Award |
2023-02-03 4:05 pm |
N/A 2033-02-01 |
bluebird bio Inc. | BLUE | Vittiglio Joseph Chief Business & Legal Officer |
150,000 | $0 | 150,000 (Direct) |
View |
2022-12-01 Option Award |
2022-12-05 4:49 pm |
N/A 2032-12-01 |
bluebird bio Inc. | BLUE | Krawtschuk Christopher Chief Financial Officer |
150,000 | $0 | 150,000 (Direct) |
View |